$IRTC
iRhythm Technologies Inc

2016 Q4 Form 10-Q Financial Statement

#000156459016029827 Filed on December 05, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $18.70M $16.78M $9.344M
YoY Change 72.32% 79.58%
Cost Of Revenue $5.790M $5.282M $3.748M
YoY Change 39.18% 40.93%
Gross Profit $12.92M $11.50M $5.596M
YoY Change 93.01% 105.47%
Gross Profit Margin 69.07% 68.52% 59.89%
Selling, General & Admin $14.96M $12.53M $9.445M
YoY Change 26.89% 32.65%
% of Gross Profit 115.81% 108.97% 168.78%
Research & Development $2.300M $1.635M $1.651M
YoY Change 27.78% -0.97%
% of Gross Profit 17.8% 14.22% 29.5%
Depreciation & Amortization -$80.00K $210.0K $120.0K
YoY Change -140.0% 75.0% -25.0%
% of Gross Profit -0.62% 1.83% 2.14%
Operating Expenses $17.26M $14.16M $11.10M
YoY Change 27.01% 27.65%
Operating Profit -$4.342M -$2.666M -$5.500M
YoY Change -37.05% -51.53%
Interest Expense -$860.0K $807.0K $222.0K
YoY Change 48.28% 263.51%
% of Operating Profit
Other Income/Expense, Net $3.700M -$602.0K -$24.00K
YoY Change -1708.7% 2408.33%
Pretax Income -$6.270M -$4.080M -$5.750M
YoY Change -18.57% -29.04%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.266M -$4.075M -$5.746M
YoY Change -18.64% -29.08%
Net Earnings / Revenue -33.5% -24.28% -61.49%
Basic Earnings Per Share
Diluted Earnings Per Share -$374.1K -$202.2K -$284.9K
COMMON SHARES
Basic Shares Outstanding 22.13M
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.1M $5.800M $7.100M
YoY Change 321.03% -18.31%
Cash & Equivalents $51.64M $5.761M $7.127M
Short-Term Investments $54.40M
Other Short-Term Assets $1.800M $1.100M $600.0K
YoY Change 100.0% 83.33%
Inventory $1.390M $1.672M $1.100M
Prepaid Expenses
Receivables $9.406M $9.308M $5.100M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $118.6M $17.85M $13.90M
YoY Change 261.29% 28.38%
LONG-TERM ASSETS
Property, Plant & Equipment $4.653M $3.363M $2.000M
YoY Change 128.54% 68.15%
Goodwill $862.0K $862.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $11.00M
YoY Change
Other Assets $3.052M $5.310M $1.700M
YoY Change 42.28% 212.35%
Total Long-Term Assets $19.55M $9.535M $4.600M
YoY Change 287.63% 107.28%
TOTAL ASSETS
Total Short-Term Assets $118.6M $17.85M $13.90M
Total Long-Term Assets $19.55M $9.535M $4.600M
Total Assets $138.2M $27.38M $18.50M
YoY Change 264.8% 48.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.103M $1.581M $700.0K
YoY Change 44.14% 125.86%
Accrued Expenses $10.17M $6.894M $5.300M
YoY Change 51.74% 30.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $13.22M $9.325M $6.300M
YoY Change 50.6% 48.02%
LONG-TERM LIABILITIES
Long-Term Debt $32.23M $31.80M $6.300M
YoY Change 5.48% 404.7%
Other Long-Term Liabilities $200.0K $4.100M $3.000M
YoY Change -93.55% 36.67%
Total Long-Term Liabilities $32.23M $31.80M $9.300M
YoY Change 5.48% 241.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.22M $9.325M $6.300M
Total Long-Term Liabilities $32.23M $31.80M $9.300M
Total Liabilities $45.59M $45.21M $15.60M
YoY Change 7.53% 189.82%
SHAREHOLDERS EQUITY
Retained Earnings -$127.2M -$120.9M
YoY Change 19.67%
Common Stock $219.7M $5.975M
YoY Change 4633.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $93.04M -$114.9M $2.900M
YoY Change
Total Liabilities & Shareholders Equity $138.2M $27.38M $18.50M
YoY Change 264.8% 48.0%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income -$6.266M -$4.075M -$5.746M
YoY Change -18.64% -29.08%
Depreciation, Depletion And Amortization -$80.00K $210.0K $120.0K
YoY Change -140.0% 75.0% -25.0%
Cash From Operating Activities -$940.0K -$2.350M -$5.160M
YoY Change -83.21% -54.46% -51.96%
INVESTING ACTIVITIES
Capital Expenditures -$940.0K -$750.0K -$670.0K
YoY Change 248.15% 11.94% 116.13%
Acquisitions
YoY Change
Other Investing Activities -$65.40M
YoY Change
Cash From Investing Activities -$66.35M -$750.0K -$670.0K
YoY Change 24474.07% 11.94% 116.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 113.2M -110.0K 30.00K
YoY Change 372.68% -466.67% -99.83%
NET CHANGE
Cash From Operating Activities -940.0K -2.350M -5.160M
Cash From Investing Activities -66.35M -750.0K -670.0K
Cash From Financing Activities 113.2M -110.0K 30.00K
Net Change In Cash 45.87M -3.210M -5.800M
YoY Change 153.85% -44.66% -187.48%
FREE CASH FLOW
Cash From Operating Activities -$940.0K -$2.350M -$5.160M
Capital Expenditures -$940.0K -$750.0K -$670.0K
Free Cash Flow $0.00 -$1.600M -$4.490M
YoY Change -100.0% -64.37% -56.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1015000
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-106266000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
91000
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
111000
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3363000
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5310000
CY2016Q3 us-gaap Assets
Assets
27380000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5577000
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1581000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5761000
CY2015Q4 us-gaap Goodwill
Goodwill
862000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2145000
CY2015Q4 us-gaap Assets
Assets
37872000
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6894000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6699000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8775000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30552000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
28000
CY2016Q3 us-gaap Goodwill
Goodwill
862000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1459000
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
850000
CY2015Q4 us-gaap Inventory Net
InventoryNet
1145000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
808000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
16780000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
9344000
us-gaap Sales Revenue Net
SalesRevenueNet
45368000
us-gaap Sales Revenue Net
SalesRevenueNet
25286000
CY2016Q3 us-gaap Cost Of Revenue
CostOfRevenue
5282000
CY2016Q3 us-gaap Liabilities
Liabilities
45212000
CY2015Q3 us-gaap Gross Profit
GrossProfit
5596000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1635000
CY2015Q3 us-gaap Cost Of Revenue
CostOfRevenue
3748000
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4549000
us-gaap Cost Of Revenue
CostOfRevenue
15097000
us-gaap Operating Expenses
OperatingExpenses
29484000
us-gaap Operating Income Loss
OperatingIncomeLoss
-11234000
us-gaap Operating Income Loss
OperatingIncomeLoss
-14737000
CY2015Q4 us-gaap Liabilities
Liabilities
42400000
CY2015Q3 us-gaap Interest Expense
InterestExpense
222000
us-gaap Interest Expense
InterestExpense
2388000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Gross Profit
GrossProfit
11498000
us-gaap Interest Expense
InterestExpense
477000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
14164000
us-gaap Gross Profit
GrossProfit
14747000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24935000
us-gaap Operating Expenses
OperatingExpenses
41505000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4847000
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
11096000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-101624000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37872000
us-gaap Gross Profit
GrossProfit
30271000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2666000
us-gaap Cost Of Revenue
CostOfRevenue
10539000
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1651000
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12529000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5500000
us-gaap Paid In Kind Interest
PaidInKindInterest
1099000
irtc Increase Decrease In Accrued Interest
IncreaseDecreaseInAccruedInterest
83000
irtc Doubtful Accounts And Contractual Allowance Adjustments
DoubtfulAccountsAndContractualAllowanceAdjustments
3384000
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
-114928000
irtc Doubtful Accounts And Contractual Allowance Adjustments
DoubtfulAccountsAndContractualAllowanceAdjustments
618000
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22126981
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9308000
CY2016Q3 us-gaap Inventory Net
InventoryNet
1672000
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1013000
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
91000
CY2016Q3 us-gaap Assets Current
AssetsCurrent
17845000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
506000
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9325000
CY2016Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
31796000
CY2016Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
27000
CY2016Q3 irtc Accrued Interest Non Current
AccruedInterestNonCurrent
119000
CY2015Q4 irtc Accrued Interest Non Current
AccruedInterestNonCurrent
96000
CY2016Q3 irtc Preferred Stock Warrant Liabilities
PreferredStockWarrantLiabilities
3945000
CY2015Q4 irtc Preferred Stock Warrant Liabilities
PreferredStockWarrantLiabilities
2949000
CY2016Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
97096000
CY2015Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
97096000
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5974000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4641000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-120903000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
646000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
293000
us-gaap Share Based Compensation
ShareBasedCompensation
1251000
us-gaap Share Based Compensation
ShareBasedCompensation
1035000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
284000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
92000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
996000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-104000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7115000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-163000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
527000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
315000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
205000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
330000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
842000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
345000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
69000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-528000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-363000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2046000
irtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-1000
irtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
14000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
344000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-55000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15617000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-12412000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1821000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1523000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27380000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-4075000
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-602000
CY2016Q3 us-gaap Interest Expense
InterestExpense
807000
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.80
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-5746000
us-gaap Net Income Loss
NetIncomeLoss
-15097000
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-10.20
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1409758
us-gaap Net Income Loss
NetIncomeLoss
-14637000
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1454307
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9445000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36658000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1364366
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
117000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-11.07
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1434583
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
470000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1821000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1523000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
82000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
312000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
12132000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1995000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2009000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
12444000
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-19447000
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-1491000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8618000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7127000
us-gaap Interest Paid
InterestPaid
1213000
us-gaap Interest Paid
InterestPaid
279000
irtc Issuance Of Warrants To Purchase Preferred Stock
IssuanceOfWarrantsToPurchasePreferredStock
44000
irtc Property And Equipment Included In Accounts Payable
PropertyAndEquipmentIncludedInAccountsPayable
152000
irtc Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
637000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contractual allowances for revenue, allowance for doubtful accounts, the useful lives of property and equipment, the recoverability of long-lived assets including the estimated usage of the printed circuit board assemblies, or PCBAs, the valuation of deferred tax assets, the fair value of the Company&#8217;s preferred and common stock and stock-based compensation. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results may differ from those estimates.</p></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with two financial institutions in the United States of America. At times, such deposits may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company has not experienced any losses on its deposits of cash and cash equivalents.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers comprising the Company&#8217;s customer base and their dispersion across many geographies. The Company does not require collateral. The Company records an allowance for doubtful accounts when it becomes probable that a receivable will not be collected. Government agencies, including CMS and the Veterans Administration, accounted for approximately 38%, 42%, 40% and 41% of the Company&#8217;s revenue for the three and nine months ended September 30, 2016 and 2015 respectively. Accounts receivable related to government agencies accounted for 30% and 34% at December 31, 2015 and September 30, 2016, respectively.</p></div>
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On October 4, 2016, the Company’s board of directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a reverse split of the Company’s issued and outstanding common stock at a 1-for- 5.882698 ratio, which was effected on October 5, 2016.
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1472000
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1177000
CY2015 irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
522000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2597000
CY2015Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
338000
CY2014Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
91000
irtc Contractual Allowance Before Adjustments
ContractualAllowanceBeforeAdjustments
1912000
CY2015 irtc Contractual Allowance Before Adjustments
ContractualAllowanceBeforeAdjustments
380000
CY2015 irtc Accounts Receivable For Contractual Allowance Write Offs Net Of Recoveries And Other Adjustments
AccountsReceivableForContractualAllowanceWriteOffsNetOfRecoveriesAndOtherAdjustments
133000
CY2016Q3 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
2250000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
irtc Loan Agreement Entered Date
LoanAgreementEnteredDate
2016-08-09
irtc Lessee Leasing Arrangements Operating Leases Space Leased
LesseeLeasingArrangementsOperatingLeasesSpaceLeased
60873
CY2015Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
300000
CY2016Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2600000
us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50%
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1257000
CY2016Q3 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
3945000
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1254000
CY2015Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
2949000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2016Q3 irtc Inventory And Printed Circuit Board Assemblies
InventoryAndPrintedCircuitBoardAssemblies
4136000
CY2015Q4 irtc Inventory And Printed Circuit Board Assemblies
InventoryAndPrintedCircuitBoardAssemblies
2776000
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5093000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3119000
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1730000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1083000
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
210000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1250000
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
646000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
293000
CY2016Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
1436000
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
1250000
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3536000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3838000
CY2016Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1106000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
652000
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
816000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
959000
irtc Monthly Base Rent
MonthlyBaseRent
320000
CY2016Q3 irtc Base Rent Payable
BaseRentPayable
13600000
CY2016Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3100000
irtc Lease Commencement Date
LeaseCommencementDate
2016-09-30
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2020-02-28
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
1467000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4741000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4774000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
4784000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y4M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y29D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.31
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.88
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.38
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.05
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.17
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.01
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M17D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M10D
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
793000
CY2016Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
16559000
CY2016Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000
CY2015Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
400000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
600000
CY2015Q4 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2016Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16645237
CY2015Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16689946
CY2015Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
11392882
CY2015Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
11046146
CY2015Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11046146
CY2015Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
13343981
CY2015Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
117495000
CY2015 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
97096000
CY2016Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
11392882
CY2016Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
11046146
CY2016Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11046146
CY2016Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
13343981
CY2016Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
117495000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
97096000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
331938000
irtc Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod
102462000
irtc Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Forfeited
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantForfeited
11135000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
240611000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2685913000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
102462000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44702000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11135000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2732538000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1794651000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2680533000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.81
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
21880000
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
15951000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
21568000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.74
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.78
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.600
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.600
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.600
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.600
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0128
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0187
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0145
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0173
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
401000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
318000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1251000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1035000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16404633
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16157337
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16404633
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16157337

Files In Submission

Name View Source Status
0001564590-16-029827-index-headers.html Edgar Link pending
0001564590-16-029827-index.html Edgar Link pending
0001564590-16-029827.txt Edgar Link pending
0001564590-16-029827-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
irtc-10q_20160930.htm Edgar Link pending
irtc-20160930.xml Edgar Link completed
irtc-20160930.xsd Edgar Link pending
irtc-20160930_cal.xml Edgar Link unprocessable
irtc-20160930_def.xml Edgar Link unprocessable
irtc-20160930_lab.xml Edgar Link unprocessable
irtc-20160930_pre.xml Edgar Link unprocessable
irtc-ex311_86.htm Edgar Link pending
irtc-ex312_85.htm Edgar Link pending
irtc-ex321_84.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending